Benadryl and Tylenol

Phase 1Small molecule

Benadryl and Tylenol is one of 6 small molecule programs targeting Acute Lymphoblastic Leukemia (ALL). It is currently in Phase 1.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Acute Lymphoblastic Leukemia (ALL)Active, not recruiting

Acute Lymphoblastic Leukemia (ALL)Phase 1

Active, not recruiting

Competition

Competitive Landscape

5 competitors in Acute Lymphoblastic Leukemia (ALL)

#DrugCompanyPhaseTrials

Blincyto

Amgen

Phase 3

3 2

Kisqali

Novartis

Phase 1

1 3

Afinitor

Novartis

Phase 1

1 4

Decadron

AAspen Global Incorporated

Phase 1

1 5

Venclexta

AbbVie

Preclinical

1 6

Benadryl and Tylenol

BBaylor College of Medicine

Phase 1

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q2 2031

Phase 1Active, not recruiting

Acute Lymphoblastic Leukemia (ALL)

NCT00840853

Clinical

Trials by Indication[1]

Acute Lymphoblastic Leukemia (ALL)1 trial

Phase I Study of the Administration of Multi-Virus-Specific Cytotoxic T Lymphocytes Expressing CD19 Chimeric Receptors for Prophylaxis or Therapy of Relapse of CD19 Positive Malignancies Post Hematopoietic Stem Cell Transplantation

Active, not recruiting·BBaylor College of Medicine·Phase 1·NCT00840853·68 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Benadryl and Tylenol. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Benadryl and Tylenol compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Benadryl and Tylenol. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Baylor College of Medicine company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 1[1]
Company: BBaylor College of Medicine

Benadryl and Tylenol

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q2 2031

Trials by Indication[1]

Acute Lymphoblastic Leukemia (ALL)1 trial

References

Drug Info

Quick Facts

Related News